相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biased Signaling at Chemokine Receptors
Jenny Corbisier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
Dick de Zeeuw et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Waka Yokoyama et al.
ARTHRITIS RESEARCH & THERAPY (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Dler Faieeq Darweesh Mahmood et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12
Cuiling Zhong et al.
CLINICAL CANCER RESEARCH (2013)
Extracellular thioredoxin: A therapeutic tool to combat inflammation
Yoshiyuki Matsuo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Resolution of inflammation: an integrated view
Almudena Ortega-Gomez et al.
EMBO MOLECULAR MEDICINE (2013)
HMGB1 and leukocyte migration during trauma and sterile inflammation
Emilie Venereau et al.
MOLECULAR IMMUNOLOGY (2013)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response
Mieke Gouwy et al.
IMMUNOLOGY LETTERS (2012)
The biochemistry and biology of the atypical chemokine receptors
G. J. Graham et al.
IMMUNOLOGY LETTERS (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The IKKα-Dependent NF-κB p52/RelB Noncanonical Pathway Is Essential To Sustain a CXCL12 Autocrine Loop in Cells Migrating in Response to HMGB1
Richard R. Kew et al.
JOURNAL OF IMMUNOLOGY (2012)
被撤回的出版物: Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) (Publication with Expression of Concern. See vol. 26, 2020) (Retracted article. See vol. 26, 2020)
Huan Yang et al.
MOLECULAR MEDICINE (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle
Michela Vezzoli et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection
Mieke Gouwy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Effect of posttranslational processing on the in vitro and in vivo activity of chemokines
Anneleen Mortier et al.
EXPERIMENTAL CELL RESEARCH (2011)
Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models
Hanna Schierbeck et al.
MOLECULAR MEDICINE (2011)
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways
Luke J. Drury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Chemokine receptor oligomerization: functional considerations
Marcus Thelen et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
Daniel Venetz et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inhibitor of NK-κB Kinases α and β Are Both Essential for High Mobility Group Box 1-Mediated Chemotaxis
Marianna Penzo et al.
JOURNAL OF IMMUNOLOGY (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes
Katrin Kuscher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells
Lara Campana et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events
Mieke Gouwy et al.
MOLECULAR PHARMACOLOGY (2008)
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
De Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein
Annalisa Porto et al.
FASEB JOURNAL (2006)
Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1
George Hoppe et al.
EXPERIMENTAL CELL RESEARCH (2006)
TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis
Tamara Loos et al.
LABORATORY INVESTIGATION (2006)
Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding
Susan E. Crown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression of a thioredoxin-related protein-1 is induced by prostaglandin E2
KY Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Fine-tuning leukocyte responses: towards a chemokine 'interactome'
C Weber et al.
TRENDS IN IMMUNOLOGY (2006)
Chemokine blockers - therapeutics in the making?
TNC Wells et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Dimerization of chemokine receptors and its functional consequences
JY Springael et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
A rich chemokine environment strongly enhances leukocyte migration and activities
S Paoletti et al.
BLOOD (2005)
Systematic micro anatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis
A Manzo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Multi-faceted strategies to combat disease by interference with the chemokine system
Z Johnson et al.
TRENDS IN IMMUNOLOGY (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
CCL22-induced responses are synergy inducing chemokines involvement of first powerfully enhanced by via CCR4:: evidence for the β-strand of chemokine
S Sebastiani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
P von Hundelshausen et al.
BLOOD (2005)
Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-γ (Mig, CXCL9)
PC Fulkerson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
H Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
I-TAC/CXCL11 is a natural antagonist for CCR5
V Petkovic et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor
H Fernando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines
U Panzer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5 - A human chemokine with a regulatory role
V Petkovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12
B Vanbervliet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes
P Ogilvie et al.
BLOOD (2003)
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma
JR Smith et al.
BLOOD (2003)
Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation
A Krug et al.
JOURNAL OF IMMUNOLOGY (2002)
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
M Mellado et al.
EMBO JOURNAL (2001)
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
P Ogilvie et al.
BLOOD (2001)
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
B Degryse et al.
JOURNAL OF CELL BIOLOGY (2001)
Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation
WW Agace et al.
CURRENT BIOLOGY (2000)
分享论文
